Elutia is a developer of customized tissue products intended to restore health and mobility to the greatest number of patients.
Elutia has raised $13.3M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2024.
Elutia's investors include MidCap Financial, Deerfield, SWK Holdings, Nantahala Capital Management, HighCape Partners.
Elutia is headquartered in Silver Spring, United States.
Elutia is a developer of customized tissue products intended to restore health and mobility to the greatest number of patients.
Elutia is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Elutia — Funding & Investors." VCBacked, June 17, 2024, https://www.vcbacked.co/company/elutia. Accessed September 30, 2026.
VCBacked. (2024). Elutia — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/elutia
{{cite web |title=Elutia — Funding & Investors |url=https://www.vcbacked.co/company/elutia |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated